ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
V03AC03 | B | Deferasirox - 360mg | 9170/945 | 65317/1 | JADENU | 360mg | 30 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Novartis Pharma Stein AG | Switzerland | 66,498,152 L.L | 10.71 | E1 | Novartis Pharma AG | Switzerland | 05/02/20 |
ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
V03AC03 | B | Deferasirox - 360mg | 9170 | 65317/1 | JADENU | 360mg | 30 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Novartis Pharma Stein AG | Switzerland | 1,090,731 L.L | 10.71 | E1 | Novartis Pharma AG | Switzerland | 05/02/20 |